Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 13 | 2024 | 2057 | 1.490 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2024 | 1513 | 1.210 |
Why?
|
| Hernia | 1 | 2024 | 15 | 0.920 |
Why?
|
| Computed Tomography Angiography | 2 | 2024 | 110 | 0.910 |
Why?
|
| Basilar Artery | 2 | 2022 | 30 | 0.900 |
Why?
|
| Lung Diseases | 1 | 2024 | 170 | 0.820 |
Why?
|
| Optic Nerve Diseases | 2 | 2013 | 18 | 0.730 |
Why?
|
| Spinal Fractures | 1 | 2021 | 36 | 0.720 |
Why?
|
| Epidural Space | 1 | 2019 | 6 | 0.660 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2019 | 4 | 0.650 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2019 | 1 | 0.630 |
Why?
|
| Retrospective Studies | 10 | 2024 | 6079 | 0.630 |
Why?
|
| Dementia | 2 | 2024 | 248 | 0.590 |
Why?
|
| Osteomyelitis | 1 | 2018 | 24 | 0.590 |
Why?
|
| Emphysema | 1 | 2018 | 35 | 0.580 |
Why?
|
| Anemia | 1 | 2019 | 119 | 0.570 |
Why?
|
| Triage | 2 | 2023 | 108 | 0.560 |
Why?
|
| Checklist | 1 | 2017 | 72 | 0.520 |
Why?
|
| Lipodystrophy | 1 | 2016 | 11 | 0.520 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 94 | 0.520 |
Why?
|
| Laryngeal Cartilages | 1 | 2015 | 3 | 0.510 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 46 | 0.500 |
Why?
|
| Ossification, Heterotopic | 1 | 2015 | 13 | 0.500 |
Why?
|
| Cartilage Diseases | 1 | 2015 | 11 | 0.490 |
Why?
|
| Adult | 14 | 2024 | 15698 | 0.490 |
Why?
|
| Spinal Cord | 3 | 2021 | 195 | 0.480 |
Why?
|
| Humans | 31 | 2024 | 59458 | 0.470 |
Why?
|
| Hippocampus | 1 | 2016 | 249 | 0.460 |
Why?
|
| Databases, Factual | 1 | 2017 | 815 | 0.440 |
Why?
|
| Carotid Artery, Internal | 1 | 2013 | 66 | 0.420 |
Why?
|
| Skull Base Neoplasms | 1 | 2013 | 5 | 0.420 |
Why?
|
| Chordoma | 1 | 2013 | 6 | 0.420 |
Why?
|
| Septum Pellucidum | 1 | 2013 | 4 | 0.420 |
Why?
|
| Septo-Optic Dysplasia | 1 | 2013 | 2 | 0.420 |
Why?
|
| Young Adult | 6 | 2024 | 4274 | 0.410 |
Why?
|
| Optic Nerve | 1 | 2013 | 25 | 0.410 |
Why?
|
| Quality Improvement | 1 | 2017 | 418 | 0.400 |
Why?
|
| Male | 16 | 2024 | 27790 | 0.400 |
Why?
|
| Migraine Disorders | 1 | 2013 | 39 | 0.400 |
Why?
|
| Brain Ischemia | 1 | 2016 | 399 | 0.390 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 5126 | 0.390 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1482 | 0.390 |
Why?
|
| Meningitis | 2 | 2024 | 18 | 0.390 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 280 | 0.380 |
Why?
|
| Hypertrophy | 2 | 2024 | 29 | 0.370 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 154 | 0.360 |
Why?
|
| Diagnosis, Differential | 4 | 2024 | 934 | 0.360 |
Why?
|
| Central Nervous System | 1 | 2013 | 193 | 0.350 |
Why?
|
| Incidental Findings | 2 | 2024 | 41 | 0.330 |
Why?
|
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2009 | 3 | 0.330 |
Why?
|
| Aged | 8 | 2024 | 13424 | 0.320 |
Why?
|
| Female | 13 | 2024 | 30772 | 0.320 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1022 | 0.320 |
Why?
|
| Vision Disorders | 1 | 2009 | 59 | 0.310 |
Why?
|
| Adolescent | 4 | 2024 | 5851 | 0.300 |
Why?
|
| Middle Aged | 8 | 2024 | 16336 | 0.300 |
Why?
|
| Systems Integration | 1 | 2004 | 26 | 0.230 |
Why?
|
| Anatomy | 1 | 2004 | 17 | 0.230 |
Why?
|
| Neck | 1 | 2024 | 46 | 0.230 |
Why?
|
| Cerebellopontine Angle | 1 | 2024 | 7 | 0.220 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2024 | 9 | 0.220 |
Why?
|
| Head | 1 | 2024 | 53 | 0.220 |
Why?
|
| Herniorrhaphy | 1 | 2024 | 69 | 0.220 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2016 | 178 | 0.220 |
Why?
|
| Transverse Sinuses | 1 | 2023 | 6 | 0.210 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2004 | 152 | 0.210 |
Why?
|
| Stroke | 2 | 2023 | 1128 | 0.200 |
Why?
|
| Learning | 1 | 2004 | 171 | 0.200 |
Why?
|
| Cerebral Veins | 1 | 2023 | 36 | 0.200 |
Why?
|
| Cognitive Dysfunction | 2 | 2024 | 309 | 0.190 |
Why?
|
| Internet | 1 | 2004 | 448 | 0.180 |
Why?
|
| Spinal Cord Diseases | 1 | 2021 | 39 | 0.170 |
Why?
|
| Arachnoid Cysts | 1 | 2020 | 5 | 0.170 |
Why?
|
| Syringomyelia | 1 | 2020 | 3 | 0.170 |
Why?
|
| Intracranial Thrombosis | 1 | 2020 | 27 | 0.170 |
Why?
|
| Prevalence | 2 | 2015 | 1255 | 0.170 |
Why?
|
| Communicable Diseases | 1 | 2021 | 85 | 0.170 |
Why?
|
| Calcinosis | 1 | 2021 | 79 | 0.170 |
Why?
|
| Radiology | 1 | 2004 | 238 | 0.170 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 39 | 0.170 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 63 | 0.170 |
Why?
|
| Encephalomyelitis | 1 | 2019 | 5 | 0.170 |
Why?
|
| Cervical Vertebrae | 1 | 2021 | 101 | 0.170 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2021 | 74 | 0.170 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2020 | 70 | 0.160 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2019 | 10 | 0.160 |
Why?
|
| Dilatation, Pathologic | 1 | 2019 | 29 | 0.160 |
Why?
|
| Cervical Cord | 1 | 2019 | 5 | 0.160 |
Why?
|
| Neuropsychological Tests | 2 | 2024 | 372 | 0.160 |
Why?
|
| Spinal Cord Compression | 1 | 2019 | 28 | 0.160 |
Why?
|
| Brain | 3 | 2019 | 1492 | 0.160 |
Why?
|
| Neuromuscular Agents | 1 | 2018 | 16 | 0.150 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1097 | 0.150 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2018 | 16 | 0.150 |
Why?
|
| Radiotherapy | 1 | 2018 | 61 | 0.140 |
Why?
|
| Myelitis | 1 | 2017 | 3 | 0.140 |
Why?
|
| Meningoencephalitis | 1 | 2017 | 7 | 0.140 |
Why?
|
| Zika Virus | 1 | 2017 | 32 | 0.140 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 32 | 0.140 |
Why?
|
| Efficiency, Organizational | 1 | 2017 | 93 | 0.130 |
Why?
|
| Trauma Centers | 1 | 2017 | 114 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 145 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 681 | 0.120 |
Why?
|
| Endovascular Procedures | 1 | 2022 | 609 | 0.120 |
Why?
|
| Pain | 1 | 2018 | 397 | 0.120 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2013 | 7 | 0.110 |
Why?
|
| Notochord | 1 | 2013 | 7 | 0.100 |
Why?
|
| Syndrome | 1 | 2013 | 170 | 0.100 |
Why?
|
| Phenotype | 1 | 2016 | 1138 | 0.100 |
Why?
|
| Neuroimaging | 2 | 2024 | 144 | 0.100 |
Why?
|
| Galactosylceramidase | 1 | 2010 | 1 | 0.080 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2010 | 4 | 0.080 |
Why?
|
| Time Factors | 1 | 2017 | 3621 | 0.080 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2008 | 8 | 0.070 |
Why?
|
| Facial Bones | 1 | 2008 | 10 | 0.070 |
Why?
|
| Skull | 1 | 2008 | 50 | 0.070 |
Why?
|
| Temporal Bone | 1 | 2008 | 37 | 0.070 |
Why?
|
| Massachusetts | 1 | 2013 | 2022 | 0.070 |
Why?
|
| Mastoidectomy | 1 | 2024 | 6 | 0.060 |
Why?
|
| Personal Satisfaction | 1 | 2004 | 76 | 0.060 |
Why?
|
| Ear, Inner | 1 | 2024 | 16 | 0.060 |
Why?
|
| Computer-Assisted Instruction | 1 | 2004 | 77 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2004 | 123 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 268 | 0.050 |
Why?
|
| Cranial Sinuses | 1 | 2023 | 12 | 0.050 |
Why?
|
| Computers | 1 | 2023 | 49 | 0.050 |
Why?
|
| Risk Factors | 1 | 2013 | 4990 | 0.050 |
Why?
|
| Dura Mater | 1 | 2023 | 33 | 0.050 |
Why?
|
| Dissection | 1 | 2023 | 45 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2004 | 192 | 0.050 |
Why?
|
| Cerebellum | 1 | 2023 | 91 | 0.050 |
Why?
|
| Recurrence | 1 | 2024 | 603 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2004 | 470 | 0.050 |
Why?
|
| Students, Medical | 1 | 2004 | 247 | 0.050 |
Why?
|
| India | 1 | 2022 | 150 | 0.050 |
Why?
|
| Infarction | 1 | 2021 | 19 | 0.050 |
Why?
|
| Methylprednisolone | 1 | 2019 | 32 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 36 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 660 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 2341 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2019 | 172 | 0.040 |
Why?
|
| Radiation | 1 | 2018 | 4 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2019 | 181 | 0.040 |
Why?
|
| Stents | 1 | 2022 | 461 | 0.040 |
Why?
|
| Algorithms | 1 | 2023 | 979 | 0.040 |
Why?
|
| Disease Progression | 1 | 2022 | 1119 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 2517 | 0.030 |
Why?
|
| Muscle Hypertonia | 1 | 2010 | 1 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2010 | 7 | 0.020 |
Why?
|
| Irritable Mood | 1 | 2010 | 16 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2010 | 29 | 0.020 |
Why?
|
| Cerebral Palsy | 1 | 2010 | 18 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 117 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 108 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 5287 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 364 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1493 | 0.020 |
Why?
|
| Pregnancy | 1 | 2010 | 2215 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 687 | 0.010 |
Why?
|
| Child | 1 | 2008 | 4201 | 0.010 |
Why?
|